Department of Medicine, Nazarbayev University School of Medicine, Kerei-Zhanibek Str. 5/1, 010000, Astana, Kazakhstan.
J Microbiol Immunol Infect. 2020 Feb;53(1):188-189. doi: 10.1016/j.jmii.2019.04.011. Epub 2019 May 21.
The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.
杨 TI 等人的研究结果表明，大环内酯类耐药和/或延迟适当的抗菌治疗可能导致儿童肺炎支原体相关肺外疾病的发生。事实上，这些疾病的临床表现和严重程度可能不同，并且可能在反复/持续暴露于肺炎支原体后免疫易感性儿童中发生。
